Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

You can also get in touch in the following ways: Atogepant is a new type of anti-calcitonin gene-related peptide (CGRP) drug, which is specifically designed to treat migraines. They work by ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo.

New migraine medicines ... these act more quickly than oral medications? AS: Exactly, because they can access the bloodstream ...